[1]
Lorenzo, V.P.; Lucio, A.; Scotti, L.; Tavares, J.F.; Barbosa, J.M.; Lima, T.K.D.; Rocha, J.D.; Scotti, M.T. Structure- and Ligand-Based Approaches
to Evaluate Aporphynic Alkaloids from Annonaceae as Multi-Target Agent Against Leishmania donovani. Current Pharmaceutical Design, 2016, 22(34), 5196-5203.
[2]
Maia, M.D.; Rodrigues, G.C.S.; de Sousa, N.F.; Scotti, M.T.; Scotti, L.; Mendonca, F.J.B. Identification of New Targets and the Virtual Screening
of Lignans against Alzheimer's Disease. Oxidative Medicine and Cellular Longevity 2020, 2020.
[3]
Maia, M.D.; Silva, J.P.E.; Nunes, T.A.D.; de Sousa, J.M.S.; Rodrigues, G.C.S.; Monteiro, A.F.M.; Tavares, J.F.; Rodrigues, K.A.D.; Mendonca, F.J.B.; Scotti, L.; Scotti, M.T. Virtual Screening and the In Vitro Assessment of the Antileishmanial Activity of Lignans. Molecules, 2020, 25(10)
[4]
Pedrosa, M.D.; da Cruz, R.M.D.; Viana, J.D.; de Moura, R.O.; Ishiki, H.M.; Barbosa, J.M.; Diniz, M.; Scotti, M.T.; Scotti, L.; Mendonca, F.J.B. Hybrid Compounds as Direct Multitarget Ligands: A Review Current Topics in Medicinal Chemistry, 2017, 17(9), 1044-1079.
[5]
Scotti, L.; Filho, F.; de Moura, R.O.; Ribeiro, F.F.; Ishiki, H.; da Silva, M.S.; Filho, J.M.B.; Scotti, M.T. Multi-Target Drugs for Neglected Diseases. Current Pharmaceutical Design, 2016, 22(21), 3135-3163.
[6]
Scotti, L.; Mendonca, F.J.B.; Moreira, D.R.M.; da Silva, M.S.; Pitta, I.R.; Scotti, M.T. SAR, QSAR and Docking of Anticancer Flavonoids and
Variants: A Review. Current Topics in Medicinal Chemistry, 2012, 12(24), 2785-2809.
[7]
Scotti, L.; Mendonca, F.J.B.; Scotti, M.T. Hybrid Compounds as Multitarget Agents in Medicinal Chemistry - Part I. Current Topics in Medicinal
Chemistry, 2017, 17(8), 843-844.
[8]
Scotti, L.; Mendonca, F.J.B.; Scotti, M.T. Hybrid Compounds as Multitarget Agents in Medicinal Chemistry - Part II. Current Topics in Medicinal
Chemistry, 2017, 17(9), 957-958.
Article Metrics
11
1